Rep. DeLauro seeks FDA rule on BPA product disclosure
This article was originally published in The Gray Sheet
Executive Summary
Rep. Rosa DeLauro, D-Conn., seeks expansion of the FDA Science Board's inquiry into the toxicity and risks of bisphenol A (BPA) to include use of the chemical in medical devices, and requests a list of all medical devices that contain the chemical, in a June 16 letter to FDA Chief Scientist Frank Torti. The agency contends that the board already plans to review all FDA regulated products containing BPA, including medical devices, and that an agency-wide BPA task force formed in April is assembling an inventory of FDA-regulated products that contain BPA. The congresswoman believes FDA should require device makers to identify which of their products include BPA, after Canada's issuance of a similar rule last month. A subcommittee of the Science Board is planning an upcoming meeting on the safety of BPA in plastics ("1The Gray Sheet" May 12, 2008, p. 6)